TempraMed Technologies has signed a definitive exclusive distribution agreement with OGM For Import Medicine and Medical Supplies to commercialize its temperature-sensitive medication storage products in Kuwait. The deal covers TempraMed's full product line and spans an initial 36-month term with minimum purchase commitments of about US$500,000. Kuwait's high diabetes and obesity rates, along with its hot climate, create strong demand for medication temperature protection solutions. This agreement supports TempraMed's strategy to expand in high-temperature markets through local exclusive partners, enhancing patient safety and product integrity in the region.
TempraMed's new Kuwait distribution agreement is notable context for readers. For those tracking the health sector, 85 of 150 US health stocks on Pluang rose while 62 fell as of Oct 15, 2026 13:21 WIB. ALMS traded at USD 6.05 with a 1-day change of -7.77%, BFLY was USD 7.51 down 7.28%, and ACB stood at USD 4.03 down 6.06%.
Mowi ASA reported that Øyvind Oaland, a primary insider, had 6,002 shares sold mistakenly at NOK 204.40 due to an error linked to closing his securities trading account. This sale was unintentional and is disclosed under Norwegian securities regulati...
Coro, a workspace cybersecurity platform designed for organizations with small IT teams, has partnered with Activa Digital, an Italian managed service provider, to deliver Coro's unified cybersecurity platform to Activa's customers. This partnership ...
Coro, a leading cybersecurity platform provider, has partnered with Italian managed service provider Activa Digital to deliver Coro's unified cybersecurity platform to Activa's clients. This collaboration addresses the growing need for simplified, co...
Sigenergy officially launched its brand in Sri Lanka, focusing on advancing the country's clean energy transition with smart energy technologies. The event featured key industry leaders and highlighted Sigenergy's innovative products like the SigenSt...
Over 15 years as CEO, Tim Cook led Apple to grow its annual revenue from $108 billion to $416 billion, with iPhone sales alone increasing from $47 billion to nearly $210 billion. This remarkable growth highlights Apple's strong market position and in...
